Clinical Trials
21 trialsNCT07595666 2026-05-19
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Universitaire Ziekenhuizen KU Leuven
Phase NA Enrolling by invitation
NCT04706910 2026-02-09
18F-DOPA II - PET Imaging Optimization
University of Alberta
Phase 3 Recruiting
NCT05370079 2026-01-15
CTRL COH
Hospices Civils de Lyon
Phase NA Recruiting
NCT02670161 2025-08-24
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
Phase 4 Enrolling by invitation
NCT06377033 2025-07-20
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
University of Pennsylvania
Phase NA Recruiting
NCT04468919 2025-05-16
BCI-FIT
Oregon Health and Science University
Phase NA Completed
NCT06914427 2025-04-06
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
Xijing Hospital
Phase NA Not yet recruiting
NCT04564495 2025-02-05
Telex
Burke Medical Research Institute
Phase NA Active not recruiting
NCT03516994 2024-05-16
EQUALACP
Duke University
Phase NA Completed
NCT02626377 2023-10-23
ICE
Centre Hospitalier Universitaire de Besancon
Phase NA Terminated
NCT03944447 2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2 Unknown
NCT03042416 2022-01-10
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
University of Alberta
Phase 3 Completed
NCT02819011 2020-02-27
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Baylor College of Medicine
Phase 2 Completed
NCT02858778 2016-08-08
Timing of Acute Palliative Care Consultation in Critically Ill Patients
Wayne State University
Phase NA Unknown
NCT02777060 2016-05-19
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
University of Arizona
Phase NA Unknown
NCT01691924 2016-03-08
Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1 Completed
NCT02111330 2016-03-08
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1 Completed
NCT02015806 2016-01-11
REMIND
Brigham and Women's Hospital
Phase NA Completed
NCT01698450 2014-10-09
Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders
University Children's Hospital, Zurich
Phase 1 Completed
NCT01931488 2013-08-29
124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown
NCT00643890 2012-02-22
Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease
Neurologix, Inc.
Phase 2 Terminated